UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 85

Sortiert nach

Treatment of PTLD with Rituximab or Chemotherapy

American journal of transplantation, 2006-03, Vol.6 (3), p.569-576

2006

Volltextzugriff (PDF)

Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma

Annals of oncology, 2008-10, Vol.19 (10), p.1770-1773

2008

Volltextzugriff (PDF)

Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivors

Annals of oncology, 2010-11, Vol.21 (11), p.2262-2266

2010

Volltextzugriff (PDF)

Akt stimulates aerobic glycolysis in cancer cells

Cancer research (Chicago, Ill.), 2004-06, Vol.64 (11), p.3892-3899

2004

Volltextzugriff (PDF)

The CD28 Signaling Pathway Regulates Glucose Metabolism

Immunity (Cambridge, Mass.), 2002-06, Vol.16 (6), p.769-777

2002

Volltextzugriff (PDF)

The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid β-oxidation

Oncogene, 2005-06, Vol.24 (26), p.4165-4173

2005

Volltextzugriff (PDF)

Activated Akt promotes increased resting T cell size, CD28‐independent T cell growth, and development of autoimmunity and lymphoma

European journal of immunology, 2003-08, Vol.33 (8), p.2223-2232

2003

Volltextzugriff (PDF)

UPDATED SAFETY AND EFFICACY DATA IN THE PHASE 1 TRIAL OF PATIENTS WITH MANTLE CELL LYMPHOMA (MCL) TREATED WITH BRUTON TYROSINE KINASE (BTK) INHIBITOR ZANUBRUTINIB (BGB‐3111)

Hematological oncology, 2019-06, Vol.37 (S2), p.245-247

2019

Volltextzugriff (PDF)

Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies

Annals of oncology, 2008-07, Vol.19 (7), p.1327-1330

2008

Volltextzugriff (PDF)

ZANUBRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA

Hematological oncology, 2019-06, Vol.37 (S2), p.45-46

2019

Volltextzugriff (PDF)

Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation

Bone marrow transplantation (Basingstoke), 2006-08, Vol.38 (3), p.211-216

2006

Volltextzugriff (PDF)

Rituximab and three dexamethasone cycles provide responses similar to splenectomy in women and those with immune thrombocytopenia of less than two years duration

Haematologica (Roma), 2014-07, Vol.99 (7), p.1264

2014

Volltextzugriff (PDF)

Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma

Bone marrow transplantation (Basingstoke), 2005-12, Vol.36 (11), p.955-961

2005

Volltextzugriff (PDF)

New monoclonal antibodies for non-Hodgkin's lymphoma

Annals of oncology, 2008-06, Vol.19 (suppl-4), p.iv60-iv62

2008

Volltextzugriff (PDF)

Utility of FDG-PET scanning in lymphoma by WHO classification

Blood, 2003-05, Vol.101 (10), p.3875-3876

2003

Volltextzugriff (PDF)

Subcutaneous injections of low-dose veltuzumab (humanized anti-CD20 antibody) are safe and active in patients with indolent non-Hodgkin’s lymphoma

Haematologica (Roma), 2011-04, Vol.96 (4), p.567-573

2011

Volltextzugriff (PDF)

Response to Second-line Therapy Defines the Potential for Cure in Patients With Recurrent Diffuse Large B-Cell Lymphoma: Implications for the Development of Novel Therapeutic Strategies

Clinical lymphoma, myeloma and leukemia, 2010-06, Vol.10 (3), p.192-196

2010

Volltextzugriff (PDF)

PF469 TISLELIZUMAB (BGB‐A317) FOR RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA: UPDATED FOLLOW‐UP EFFICACY AND SAFETY RESULTS FROM A PHASE 2 STUDY

HemaSphere, 2019-06, Vol.3 (S1), p.185-186

2019

Volltextzugriff (PDF)

The THRIL (thalidomide [T], rituximab [R], and lenalidomide [L]) regimen for chronic lymphocytic leukemia, small lymphocytic lymphoma, and mantle cell lymphoma: daily alternating IMiDs and rituximab maintenance

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.7079-7079

2008

Volltextzugriff (PDF)

Subcutaneous injections of low doses of veltuzumab (humanized anti-CD20 antibody): Objective responses in B-cell malignancies

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.8530-8530

2009

Volltextzugriff (PDF)

Analysis of immunoglobulin and T-cell receptor gene rearrangements in human fetal bone marrow B lineage cells

Blood, 1990-09, Vol.76 (6), p.1196-1200

1990

Volltextzugriff (PDF)

Gemcitabine-induced pericardial effusion and tamponade after unblocked cardiac irradiation

Leukemia & lymphoma, 2005-09, Vol.46 (9), p.1313-1320

2005

Volltextzugriff (PDF)

Differentiation of normal human pre-B cells in vitro

The Journal of experimental medicine, 1990-07, Vol.172 (1), p.325-334

1990

Volltextzugriff (PDF)

IPTES: A concurrent engineering approach for real-time software development

Real-time systems, 1993-05, Vol.5 (2-3), p.139-152

1993

Volltextzugriff (PDF)

Radiography of the nasolacrimal passageways

Medical radiography and photography, 1949, Vol.25 (3), p.66

1949

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(68)

Publikationsform

Sprache

Englisch
(85)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Humans
(42)
Science & Technology
(41)
Life Sciences & Biomedicine
(38)
Oncology
(23)
Female
(20)
Male
(20)
Middle Aged
(20)
Biological And Medical Sciences
(19)
Medical Sciences
(18)
Adult
(16)
Aged
(16)
Hematologic And Hematopoietic Diseases
(16)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(15)
Hematology
(14)
Treatment Outcome
(14)
Aged, 80 And Over
(11)
Lymphoma
(11)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(9)
Rituximab
(9)
Disease-Free Survival
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Treatment of PTLD with Rituximab or Chemotherapy

Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma

Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivors

Akt stimulates aerobic glycolysis in cancer cells

The CD28 Signaling Pathway Regulates Glucose Metabolism

The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid β-oxidation

Activated Akt promotes increased resting T cell size, CD28‐independent T cell growth, and development of autoimmunity and lymphoma

UPDATED SAFETY AND EFFICACY DATA IN THE PHASE 1 TRIAL OF PATIENTS WITH MANTLE CELL LYMPHOMA (MCL) TREATED WITH BRUTON TYROSINE KINASE (BTK) INHIBITOR ZANUBRUTINIB (BGB‐3111)

Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies

ZANUBRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA

Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation

Rituximab and three dexamethasone cycles provide responses similar to splenectomy in women and those with immune thrombocytopenia of less than two years duration

Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma

New monoclonal antibodies for non-Hodgkin's lymphoma

Utility of FDG-PET scanning in lymphoma by WHO classification

Subcutaneous injections of low-dose veltuzumab (humanized anti-CD20 antibody) are safe and active in patients with indolent non-Hodgkin’s lymphoma

Response to Second-line Therapy Defines the Potential for Cure in Patients With Recurrent Diffuse Large B-Cell Lymphoma: Implications for the Development of Novel Therapeutic Strategies

PF469 TISLELIZUMAB (BGB‐A317) FOR RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA: UPDATED FOLLOW‐UP EFFICACY AND SAFETY RESULTS FROM A PHASE 2 STUDY

The THRIL (thalidomide [T], rituximab [R], and lenalidomide [L]) regimen for chronic lymphocytic leukemia, small lymphocytic lymphoma, and mantle cell lymphoma: daily alternating IMiDs and rituximab maintenance

Subcutaneous injections of low doses of veltuzumab (humanized anti-CD20 antibody): Objective responses in B-cell malignancies

Analysis of immunoglobulin and T-cell receptor gene rearrangements in human fetal bone marrow B lineage cells

Gemcitabine-induced pericardial effusion and tamponade after unblocked cardiac irradiation

Differentiation of normal human pre-B cells in vitro

IPTES: A concurrent engineering approach for real-time software development

Radiography of the nasolacrimal passageways

Suchergebnisse filtern